Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Interest & Investment Income (2017 - 2025)

Anaptysbio (ANAB) has disclosed Interest & Investment Income for 9 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 52.35% year-over-year to $2.5 million, compared with a TTM value of $13.5 million through Dec 2025, down 31.8%, and an annual FY2025 reading of $13.5 million, down 31.8% over the prior year.
  • Interest & Investment Income was $2.5 million for Q4 2025 at Anaptysbio, down from $2.9 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $5.3 million in Q3 2024 and bottomed at $64000.0 in Q3 2021.
  • Average Interest & Investment Income over 5 years is $3.0 million, with a median of $3.7 million recorded in 2022.
  • The sharpest move saw Interest & Investment Income plummeted 90.2% in 2021, then soared 5545.59% in 2022.
  • Year by year, Interest & Investment Income stood at $68000.0 in 2021, then skyrocketed by 5545.59% to $3.8 million in 2022, then increased by 27.12% to $4.9 million in 2023, then rose by 7.85% to $5.3 million in 2024, then crashed by 52.35% to $2.5 million in 2025.
  • Business Quant data shows Interest & Investment Income for ANAB at $2.5 million in Q4 2025, $2.9 million in Q3 2025, and $3.7 million in Q2 2025.